Bcr-abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: A novel model for chronic myelogenous leukemia

Blood

Volumn 92, Issue 10, 1998, Pages 3829-3840

  Zhang, Xiaowu ^b   Ren, Ruibao ^a  

^a BRANDEIS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC MYELOID LEUKEMIA; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; IMMUNOBLOTTING; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

EID: 0032533620     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.10.3829.422k14_3829_3840     Document Type: Article

References (69)

1. Goldman JM: Chronic myeloid leukemia. Curr Opin Hematol 4:277, 1997
2. Cortes JE, Talpaz M, Kantarjian H: Chronic myelogenous leukemia: A review. Am J Med 100:555, 1996
3. Enright H, McGlave PB: Chronic myelogenous leukemia. Curr Opin Hematol 3:303, 1996
4. Melo JV: The diversity of Bcr-Abl fusion proteins and their relationship to leukemia phenotype. Blood 88:2375, 1996
5. Gotoh A, Broxmeyer HE: The function of Bcr-Abl and related proto-oncogenes. Curr Opin Hematol 4:3, 1997
6. Raitano AB, Whang YE, Sawyers CL: Signal transduction by wild-type and leukemogenic Abl proteins. Biochim Biophys Acta 1333:201, 1997
7. Sattler M, Salgia R: Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL. Cytokine Growth Factor Rev 8:63, 1997
8. Metcalf D, Moore MAS, Sheridan JW, Spitzer G: Responsiveness of human granulocytic leukemic cells to colony-stimulating factor. Blood 43:847, 1974
9. Moore MA, Williams N, MetCalf D: In vitro colony formation by normal and leukemic human hematopoietic cells: Characterization of the colony-forming cells. J Natl Cancer Inst 50:603, 1973
10. Goldman JM, Th'ng KH, Lowenthal RM: In vitro colony forming cells and colony stimulating factor in chronic granulocytic leukaemia. Br J Cancer 30:1, 1974
11. Lansdorp PM, Oosterhof F, Zeijlemaker WP: Colony-forming cells in chronic granulocytic leukemia - I. Proliferative responses to growth factors. Leuk Res 9:1337, 1985
12. Anderson S, Mladenovic J: The Bcr-Abl oncogene requires both kinase activity and src-homology 2 domain to induce cytokine secretion. Blood 87:238, 1996
13. Hariharan IK, Adams JM, Cory S: bcr-abl oncogene renders myeloid cell line factor independent: Potential autocrine mechanism in chronic myeloid leukemia. Oncogene Res 3:387, 1988
14. Sirard C, Laneuville P, Dick JE: Expression of bacr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism. Blood 83:1575, 1994
15. Metcalf D: Hemopoietic colonies: In vitro cloning of normal and leukemic cells. Rec Results Cancer Res 61:120, 1977
16. Lajmanovich A, Berthier R, Schweitzer A, Leger J, Hollard D: Constitutive expression of GM-CSF mRNA by CML blast cells is correlated with endogenous megakaryocytic colony formation. Leukemia 7:1211, 1993
17. el-Ahmady O, Mansour M, Kamel H, Baker A: Granulocyte-macrophage colony stimulating factor and interleukin-6 enhanced white blood cell synthesis of leukotrienes in chronic myelogenous leukemia. Anticancer Res 17:3179, 1997
18. Jonuleit T, Peschel C, Schwab R, van der Kuip H, Buchdunger E, Fischer T, Huber C, Aulitzky WE: Bcr-Abl kinase promotes cell cycle entry of primary myeloid CML cells in the absence of growth factors. Br J Haematol 100:295,1998
19. Wong PMC, Chung S-W, Dunbar CE, Bodine DM, Ruscetti S, Nienhuis AW: Retrovirus-mediated transfer and expression of the interleukin-3 gene in mouse hematopoietic cells result in a myeloproliferative disorder. Mol Cell Biol 9:798, 1989
20. Hawley RG, Fong AZC, Burns BF, Hawley TS: Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J Exp Med 176:1149, 1992
21. Chang JM, Metcalf D, Gonda TJ, Johnson GR: Long term exposure ro retrovirally expressed granulocyte-colony-stimulating factor induces a nonneoplastic granulocytis and progenitor cell hyperplasia without tissue damage in mice. J Clin Invest 84:1488, 1989
22. Lang RA, Metcalf D, Cuthbertson RA, Lyons I, Stanley E, Kelso A, Kannourakis G, Williamson DJ, Klintworth GK, Gonda TJ, Dunn AR: Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell 51:675, 1987
23. Johnson GR, Gonda TJ, Metcalf D, Hariharan IK, Cory S: A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocytemacrophage colony stimulating factor. EMBO J 8:441, 1989
24. Daley G, Baltimore D: Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210 bcr/abl protein. Proc Natl Acad Sci USA 85:9312, 1988
25. McLaughlin J, Chianese E, Witte ON: In vitro transformation of immature hematopoietic cells by the P210 bcr/abl oncogene product of the Philadelphia chromosome. Proc Natl Acad Sci USA 84:6558, 1987
26. McLaughlin J, Chianese E, Witte ON: Alternative forms of the bcr-abl oncogene have quantitatively different potencies for stimulation of immature lymphoid cells. Mol Cell Biol 9:1866, 1989
27. Young JC, Witte ON: Selective transformation of primitive lymphoid cells by the bcr/abl oncogene expressed in long-term lymphoid or myeloid cultures. Mol Cell Biol 8:4079, 1988
28. Kelliher MA, Weckstein DJ, Knott AG, Wortis HH, Rosenberg N: ABL oncogenes directly stimulate two distinct target cells in bone marrow from 5-fluorouracil-treated mice. Oncogene 8:1249, 1993
29. Lugo TG, Witte ON: The bcr-abl oncogene transforms rat-1 cells and cooperates with v-myc. Mol Cell Biol 9:1263, 1989
30. Renshaw MW, Mcwhirter JR, Wang JYJ: The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation. Mol Cell Biol 15:1286, 1995
31. Daley GQ, Van Etten RA, Baltimore D: Induction of chronic myelogenous leukemia in mice by the P210 bcr/abl gene of the Philadelphia chromosome. Science 247:824, 1990
32. Elefanty AG, Hariharan IK, Cory S: bcr-abl, the hallmark of chronic myeloid leukemia in man, induces multiple hematopoietic neoplasms in mice. EMBO J 9:1069, 1990
33. Kelliher MA, McLaughlin J, Witte ON, Rosenberg N: Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci USA 87:6649, 1990
34. Gishizky ML, Johnson-White J, Witte ON: Efficient transplantation of Bcr-Abl-induced chronic myelogenous leukemia-like syndrome in mice. Proc Natl Acad Sci USA 90:3755, 1993
35. Hariharan IK, Harris AW, Crawford M, Abud H, Webb E, Cory S, Adams JM: A bcr-v-abl oncogene induces lymphomas in transgenic mice. Mol Cell Biol 9:2798, 1989
36. Honda H, Fujii T, Takatoku M, Mano H, Witte ON, Yazaki Y, Hirai H: Expression of p210bcr-abl by metallothionein promoter induced T-cell leukemia in transgenic mice. Blood 85:2853, 1995
37. Voncken JW, Kaartinen V, Pattengale PK, Germeraad WT, Groften J, Heisterkamp N: BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice. Blood 86:4603, 1995
38. Honda H, Oda H, Suzuki T, Takahashi T, Witte ON, Ozawa K, Ishikawa T, Yazaki Y, Hirai H: Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: A novel transgenic model for human Ph1-positive leukemias. Blood 91:2067, 1998
39. Hawley RG, Lieu FHL, Fong AZC, Hawley TS: Versatile retroviral vectors for potential use in gene therapy. Gene Ther 1:136, 1995
40. Chen BK, Feinberg MB, Baltimore D: The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth. J Virol 71:5495, 1997
41. Pear WS, Nolan GP, Scott ML, Baltimore D: Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90:8392, 1993
42. Pear WS, Aster JC, L. SM, Hasserjian RP, Soffer B, Sklar J, Baltimore D: Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med 183:2283, 1996
43. Ren R, Ye Z, Baltimore D: Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev 8:783, 1994
44. Lugo TG, Pendergast A-M, Muller AJ, Witte ON: Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247:1079, 1990
45. Schwartzberg PL, Xing L, Hoffmann O, Lowell CA, Garrett L, Boyce BF, Varmus HE: Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice. Genes Dev 11:2835, 1997
46. Hoffmann FM: Drosophila abl and genetic redundancy in signal transduction. Trends Genet 7:351, 1991
47. Warmuth M, Bergmann M, Prieß A, Häuslmann K, Emmerich B, Hallek M: The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr. J Biol Chem 272:33260, 1997
48. Lindemann A, Mertelsmann R: Interleukin-3 and its receptor. Cancer Treat Res 80:107, 1995
49. Vickers M: Estimation of the number of mutations necessary to cause chronic myeloid leukaemia from epidemiological data. Br J Haematol 94:1, 1996
50. Strife A, Lambek C, Wisniewski D, Wachter M, Gulati SC, Clarkson BD: Discordant maturation as the primary biological defect in chronic myelogenous leukemia. Cancer Res 48:1035, 1988
51. Strife A, Clarkson B: Biology of chronic myelogenous leukemia: Is discordant maturation the primary defect? Semin Hematol 25:1, 1988
52. Eaves CJ, Eaves AC: Stem cell kinetics. Clin Haematol 10:233, 1997
53. Cambier N, Chopra R, Strasser A, Metcalf D, Elefanty AG: BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner. Oncogene 16:335, 1998
54. Hildebrand FLJ, Rosenow ECd, Habermann TM, Tazelaar HD: Pulmonary complications of leukemia. Chest 98:1233, 1990
55. Eisner HA, Duhrsen U, Hollwitz B, Kaulfers PM, Hossfeld DK: Fatal pulmonary hemorrhage in patients with acute leukemia and fulminant pneumonia caused by Stenotrophomonas maltophilia. Ann Hematol 74:155, 1997
56. Bernini JC, Timmons CF, Sandler ES: Acute basophilic leukemia in a child. Anaphylactoid reaction and coagulopathy secondary to vincristine-mediated degranulation. Cancer 75:110, 1995
57. Warrell RPJ, Maslak P, Eardley A, Heller G, Miller WHJ, Frankel SR: Treatment of acute promyelocytic leukemia with all-trans retinoic acid: An update of the New York experience. Leuk Suppl 2:33, 1994
58. Srivastava A, Gottlieb D, Brad stock KF: Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation. Bone Marrow Transplant 15:863, 1995
59. van Buchem MA, Hogendoorn PC, Levelt CN, van Hengel P, Colly LP, Kluin PM, Willemze R: Development of pulmonary leukostasis in experimental myelocytic leukemia in the Brown-Norway rat. Leukemia 6:142, 1992
60. 59a. Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML, Baltimore D: Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 92:3780, 1998
61. Nimer SD, Uchida H: Regulation of granulocyte-macrophage colony-stimulating factor and interleukin 3 expression. Stem Cells 13:324, 1995
62. Hara T, Miyajima A: Function and signal transaction mediated by the interleukin 3 receptor system in hematopoiesis. Stem Cells 14:605, 1996
63. Miyajima A, Kinoshita T, Wakao H, Hara T, Yoshimura A, Nishinakamura R, Murray R, Mui A: Signal transduction by the GM-CSF, IL-3 and IL-5 receptors. Leuk Suppl 3:418, 1997
64. Lantz CS, Boesiger J, Song CH, Mach N, Kobayashi T, Mulligan RC, Nawa Y, Dranoff G, Galli SJ: Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392:90, 1998
65. Draoff G, Crawford AD, Sadelain M, Ream B, Rashid A, Bronson RT, Dickersin GR, Bachurski CJ, Mark EL, Whitsett JA, et al: Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264:713, 1994
66. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JA, Maher DW, Cebon J, Sinickas V, Dunn AR: Granulocyte/ macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 91:5592, 1994
67. Iversen PO, Rodwell RL, Pitcher L, Taylor KM, Lopez AF: Inhibition of proliferation and induction of apoptosis in juvenile myelomonocytic leukemic cells by the granulocyte-macrophage colony-stimulating factor analogue E21R. Blood 88:2634, 1996
68. Iversen PO, Lewis ID, Turczynowicz S, Hasle H, Niemeyer C, Schmiegelow K, Bastiras S, Biondi A, Hughes IP, Lopez AF: Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice. Blood 90:4910, 1997
69. Metcalf D, Nicola NA: The Hemopoietic Colony-Stimulating Factors. From Biology to Clinical Applications. Cambridge, MA, Cambridge, 1995